Mark Houston, MD, MS, FACP, FAHA

(2-AUDIO CD DISC SET) State of the Science Evaluation and Nonpharmacologic Treatment of Dyslipidemia

WIA107-061/062

Fibromyalgia/CFS, Adrenal Dysfunction, Dyslipidemia, Migraines, Diabetes & Hypothyroid ~ July, 2010

  • Sale
  • Regular price $20.00


Utilizing expanded laboratory testing for evaluation of lipids and cardiovascular risk assessment. An in depth look at the evidence-based nutritional and botanical therapies for treatment of dyslipidemia.